Published in BMJ on February 01, 2006
Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med (2015) 4.57
Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ (2010) 3.37
Delirium in older people. BMJ (2007) 2.77
Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin. Int J Clin Pract (2008) 2.66
Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease. J Neurol Neurosurg Psychiatry (2006) 2.48
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med (2009) 2.41
The cognitive impact of anticholinergics: a clinical review. Clin Interv Aging (2009) 1.86
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults. JAMA Neurol (2016) 1.76
Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol (2013) 1.61
Antidepressant Use and Cognitive Decline: The Health and Retirement Study. Am J Med (2015) 1.41
Cumulative anticholinergic exposure is associated with poor memory and executive function in older men. J Am Geriatr Soc (2008) 1.32
Multi-dose drug dispensing and inappropriate drug use: A nationwide register-based study of over 700,000 elderly. Scand J Prim Health Care (2008) 1.30
Long-term anticholinergic use and the aging brain. Alzheimers Dement (2012) 1.12
A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder. Br J Clin Pharmacol (2011) 1.09
Managing polypharmacy in a 77-year-old woman with multiple prescribers. CMAJ (2013) 1.08
Dual use of bladder anticholinergics and cholinesterase inhibitors: long-term functional and cognitive outcomes. J Am Geriatr Soc (2008) 1.07
Memory disorders associated with consumption of drugs: updating through a case/noncase study in the French PharmacoVigilance Database. Br J Clin Pharmacol (2011) 1.05
Anticholinergic drug use and risk for dementia: target for dementia prevention. Eur Arch Psychiatry Clin Neurosci (2010) 1.03
Potentially inappropriate medication use in older adults with mild cognitive impairment. J Gerontol A Biol Sci Med Sci (2009) 1.01
Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis. Br J Clin Pharmacol (2015) 0.98
Drugs with anticholinergic properties: cognitive and neuropsychiatric side-effects in elderly patients. Neurol Sci (2009) 0.95
Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. J Am Geriatr Soc (2014) 0.95
Nonmotor manifestations of dystonia: a systematic review. Mov Disord (2011) 0.95
Serum anticholinergic activity and cerebral cholinergic dysfunction: an EEG study in frail elderly with and without delirium. BMC Neurosci (2008) 0.94
α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics. Br J Clin Pharmacol (2011) 0.93
Exploration of 100 commonly used drugs and supplements on cognition in older adults. Alzheimers Dement (2013) 0.91
Mild cognitive impairment in adult: A neuropsychological review. Ann Indian Acad Neurol (2013) 0.90
Characterizing healthy samples for studies of human cognitive aging. Front Aging Neurosci (2012) 0.89
Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review. BMC Geriatr (2015) 0.88
Rationale for the use of anticholinergic agents in overactive bladder with regard to central nervous system and cardiovascular system side effects. Korean J Urol (2013) 0.86
Evidence-based guidelines for the treatment of lower urinary tract symptoms related to uncomplicated benign prostatic hyperplasia in Italy: updated summary from AURO.it. Ther Adv Urol (2012) 0.86
Drug Burden Index in older adults: theoretical and practical issues. Clin Interv Aging (2014) 0.86
Management of overactive bladder. Nat Rev Urol (2010) 0.85
Cognitive decline in older persons initiating anticholinergic medications. PLoS One (2013) 0.85
Anticholinergic drugs and their effects on delirium and mortality in the elderly. Dement Geriatr Cogn Dis Extra (2011) 0.84
Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in postmenopausal women. Clin Drug Investig (2012) 0.84
Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease. J Chem Neuroanat (2011) 0.83
Turning over the rocks: role of anticholinergics and benzodiazepines in cognitive decline and falls. Can Fam Physician (2014) 0.83
Higher anticholinergic drug scale (ADS) scores are associated with peripheral but not cognitive markers of cholinergic blockade. Cross sectional data from 21 Norwegian nursing homes. Br J Clin Pharmacol (2013) 0.83
Use of CNS medications and cognitive decline in the aged: a longitudinal population-based study. BMC Geriatr (2011) 0.81
Effect of Anticholinergic Medications on Falls, Fracture Risk, and Bone Mineral Density Over a 10-Year Period. Ann Pharmacother (2014) 0.81
Effect of Scopolamine Butylbromide on Clozapine-induced Hypersalivation in Schizophrenic Patients: A Case Series. Clin Psychopharmacol Neurosci (2015) 0.81
Psychotropic drugs and the risk of fractures in old age: a prospective population-based study. BMC Public Health (2010) 0.81
Different methods, different results-how do available methods link a patient's anticholinergic load with adverse outcomes? Eur J Clin Pharmacol (2015) 0.80
Clarifying delirium management: practical, evidenced-based, expert recommendations for clinical practice. J Palliat Med (2013) 0.80
Refractory overactive bladder: a common problem? Int Urogynecol J (2015) 0.80
Cohorts based on decade of death: no evidence for secular trends favoring later cohorts in cognitive aging and terminal decline in the AHEAD study. Psychol Aging (2012) 0.80
CNS medications as predictors of precipitous cognitive decline in the cognitively disabled aged: a longitudinal population-based study. Dement Geriatr Cogn Dis Extra (2012) 0.80
Botulinum toxin-A for idiopathic overactivity of the vesical detrusor: a 2-year follow-up. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.80
Retrospective identification and characterization of mild cognitive impairment from a prospective population cohort. Am J Geriatr Psychiatry (2010) 0.79
Overactive bladder: the importance of tailoring treatment to the individual patient. J Multidiscip Healthc (2011) 0.78
Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: study protocol for a randomized controlled trial. Trials (2012) 0.77
A predictive in vitro model of the impact of drugs with anticholinergic properties on human neuronal and astrocytic systems. PLoS One (2015) 0.76
Comedication and Treatment Length in Users of Acetylcholinesterase Inhibitors. Dement Geriatr Cogn Dis Extra (2017) 0.75
Use of Medicines with Anticholinergic and Sedative Effect Before and After Initiation of Anti-Dementia Medications. Drugs Real World Outcomes (2015) 0.75
Anticholinergic medication use and dementia: latest evidence and clinical implications. Ther Adv Drug Saf (2016) 0.75
Serum Anticholinergic Activity and Cognitive and Functional Adverse Outcomes in Older People: A Systematic Review and Meta-Analysis of the Literature. PLoS One (2016) 0.75
Tolterodine extended release is well tolerated in older subjects. Int J Clin Pract (2009) 0.75
Psychiatry and primary care. Psychiatry (Edgmont) (2006) 0.75
The relationship between anticholinergic medications and Mini-Cog scores in older adults receiving home health care. Consult Pharm (2009) 0.75
Anticholinergic burden and cognitive function in a large German cohort of hospitalized geriatric patients. PLoS One (2017) 0.75
Long-term trihexyphenidyl exposure alters neuroimmune response and inflammation in aging rat: relevance to age and Alzheimer's disease. J Neuroinflammation (2016) 0.75
Anticholinergic medication use and falls in postmenopausal women: findings from the women's health initiative cohort study. BMC Geriatr (2016) 0.75
Over-Prescribed Medications, Under-Appreciated Risks: A Review of the Cognitive Effects of Anticholinergic Medications in Older Adults. Mo Med (2016) 0.75
Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database. Br J Clin Pharmacol (2016) 0.75
Drug-induced cerebral glucose metabolism resembling Alzheimer's Disease: a case study. BMC Psychiatry (2015) 0.75
Delirium in early-stage alzheimer's disease: enhancing cognitive reserve as a possible preventive measure. J Gerontol Nurs (2009) 0.75
Assessment of cognitive safety in clinical drug development. Drug Discov Today (2015) 0.75
Perioperative Management of Elderly Patients with Gastrointestinal Malignancies: The Contribution of Anesthesia. Visc Med (2017) 0.75
Navigating Long-Term Care. Gerontol Geriatr Med (2017) 0.75
Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res (2017) 0.75
Anticholinergic drugs and functional, cognitive impairment and behavioral disturbances in patients from a memory clinic with subjective cognitive decline or neurocognitive disorders. Alzheimers Res Ther (2017) 0.75
The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia. J Clin Psychopharmacol (2017) 0.75
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1. Arch Neurol (2003) 4.82
Classification criteria for mild cognitive impairment: a population-based validation study. Neurology (2001) 3.92
Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology (1996) 2.31
Incidence and risk factors for mild cognitive impairment: a population-based three-year follow-up study of cognitively healthy elderly subjects. Dement Geriatr Cogn Disord (2004) 2.12
Drug-induced cognitive impairment in the elderly. Drugs Aging (1999) 1.87
Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology (2003) 1.82
Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium. Am J Psychiatry (1992) 1.78
Functional MRI detection of pharmacologically induced memory impairment. Proc Natl Acad Sci U S A (2001) 1.74
Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry (2003) 1.70
Mild cognitive impairment: an epidemiological perspective. Dialogues Clin Neurosci (2004) 1.53
Anticholinergic side-effects of drugs in elderly people. J R Soc Med (2000) 1.51
The problems of anticholinergic adverse effects in older patients. Drugs Aging (1993) 1.43
Hypersensitivity to scopolamine in the elderly. Psychopharmacology (Berl) (1992) 1.33
The risk of anticholinergic toxicity in the elderly: a study of prescribing practices in two populations. J Gerontol (1983) 1.27
Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: a 4-year case-control study. Int Psychogeriatr (2002) 1.24
Scopolamine effects on memory, language, visuospatial praxis and psychomotor speed. Psychopharmacology (Berl) (1990) 1.10
Predicting CNS permeability of drug molecules: comparison of neural network and support vector machine algorithms. J Comput Biol (2002) 1.10
The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population. J Neuropsychiatry Clin Neurosci (1991) 1.05
A pharmacoepidemiological evaluation of anticholinergic prescribing patterns in the elderly. Pharmacoepidemiol Drug Saf (1996) 1.04
Cholinergic modulation of preattentive auditory processing in aging. Neuroimage (2005) 1.04
Aging, memory, and the cholinergic system: a study of dichotic listening. Neurobiol Aging (1980) 0.89
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Mild cognitive impairment. Lancet (2006) 10.21
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Mild cognitive impairment is not a clinical entity and should not be treated. Arch Neurol (2005) 4.26
Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA (2009) 4.01
Relationship between blood pressure and outdoor temperature in a large sample of elderly individuals: the Three-City study. Arch Intern Med (2009) 3.38
Sleep and depression. J Clin Psychiatry (2005) 2.78
Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn (2004) 2.71
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol (2012) 2.65
Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study. Arch Intern Med (2009) 2.41
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet (2010) 2.21
Anxiety and mortality risk in community-dwelling elderly people. Br J Psychiatry (2013) 2.13
Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset. Ann Neurol (2004) 2.03
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement (2013) 1.98
Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc (2009) 1.87
Relationship between blood pressure and depression in the elderly. The Three-City Study. J Hypertens (2008) 1.79
Frailty among community-dwelling elderly people in France: the three-city study. J Gerontol A Biol Sci Med Sci (2008) 1.70
Resilience and mental health. Clin Psychol Rev (2010) 1.64
Alternative Healthy Eating Index and mortality over 18 y of follow-up: results from the Whitehall II cohort. Am J Clin Nutr (2011) 1.54
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care (2008) 1.52
Inappropriate medication use and risk of falls--a prospective study in a large community-dwelling elderly cohort. BMC Geriatr (2009) 1.50
Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One (2011) 1.43
Revised criteria for mild cognitive impairment: validation within a longitudinal population study. Dement Geriatr Cogn Disord (2006) 1.42
Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study. Stroke (2009) 1.38
Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens (2006) 1.34
Plasma osteoprotegerin is associated with mortality in hemodialysis patients. J Am Soc Nephrol (2005) 1.28
Insomnia symptoms in older adults: associated factors and gender differences. Am J Geriatr Psychiatry (2011) 1.28
Ascertaining late-life depressive symptoms in Europe: an evaluation of the survey version of the EURO-D scale in 10 nations. The SHARE project. Int J Methods Psychiatr Res (2008) 1.27
Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period. Curr Med Res Opin (2005) 1.26
Methods of synthesizing qualitative research studies for health technology assessment. Int J Technol Assess Health Care (2011) 1.26
IPA survey of brief cognitive screening instruments. Int Psychogeriatr (2006) 1.26
Do we really know the cause of death of the very old? Comparison between official mortality statistics and cohort study classification. Eur J Epidemiol (2009) 1.25
Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int (2005) 1.22
Assay for measurement of intact B-type natriuretic peptide prohormone in blood. Clin Chem (2006) 1.22
Leisure activity and cognitive decline in incident Alzheimer disease. Arch Neurol (2007) 1.21
Target risk factors for dementia prevention: a systematic review and Delphi consensus study on the evidence from observational studies. Int J Geriatr Psychiatry (2014) 1.21
Excessive sleepiness is predictive of cognitive decline in the elderly. Sleep (2012) 1.18
Suicidal behavior is associated with reduced corpus callosum area. Biol Psychiatry (2011) 1.17
Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment. J Clin Neurophysiol (2007) 1.15
Insomnia and daytime sleepiness are risk factors for depressive symptoms in the elderly. Sleep (2011) 1.14
Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet (2013) 1.11
Cerebrospinal fluid collection tubes: a critical issue for Alzheimer disease diagnosis. Clin Chem (2012) 1.11
Association of adverse childhood environment and 5-HTTLPR Genotype with late-life depression. J Clin Psychiatry (2009) 1.11
Family studies in insomnia. J Psychosom Res (2005) 1.11
Late-life depression and mortality: influence of gender and antidepressant use. Br J Psychiatry (2008) 1.10
Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis (2011) 1.10
Lipodystrophy and metabolic disorders in HIV-1-infected adults on 4- to 9-year antiretroviral therapy in Senegal: a case-control study. J Acquir Immune Defic Syndr (2009) 1.08
Life-time estrogen exposure and cognitive functioning in later life. Psychoneuroendocrinology (2008) 1.07
Increased thrombin generation is associated with acute ischemic stroke but not with coronary heart disease in the elderly: the Three-City cohort study. Arterioscler Thromb Vasc Biol (2011) 1.05
Effect of cognitive behavioural therapy for insomnia on sleep architecture and sleep EEG power spectra in psychophysiological insomnia. J Sleep Res (2004) 1.05
Distension of the carotid artery and risk of coronary events: the three-city study. Arterioscler Thromb Vasc Biol (2008) 1.04
Social activity and improvement in depressive symptoms in older people: a prospective community cohort study. Am J Geriatr Psychiatry (2009) 1.03
Memory complaints in healthy young and elderly adults: reliability of memory reporting. Aging Ment Health (2008) 1.02
The metabolic syndrome and the carotid artery structure in noninstitutionalized elderly subjects: the three-city study. Stroke (2007) 1.02
Prevention trials in Alzheimer's disease: an EU-US task force report. Prog Neurobiol (2011) 1.02
Patient and public attitudes to and awareness of clinical practice guidelines: a systematic review with thematic and narrative syntheses. BMC Health Serv Res (2014) 1.01
Hypnotics and mortality in an elderly general population: a 12-year prospective study. BMC Med (2013) 1.01
Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid. Brain Res (2010) 1.01
Impact of the 2008-2012 French Alzheimer Plan on the use of cerebrospinal fluid biomarkers in research memory center: the PLM Study. J Alzheimers Dis (2013) 1.00
Abnormal reactions to environmental stress in elderly persons with anxiety disorders: evidence from a population study of diurnal cortisol changes. J Affect Disord (2007) 1.00
Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes. J Alzheimers Dis (2012) 1.00
5-HTTLPR genotype, stressful life events and late-life depression: no evidence of interaction in a French population. Neurobiol Aging (2008) 1.00
Biomarkers of inflammation and malnutrition associated with early death in healthy elderly people. J Am Geriatr Soc (2008) 0.99
Intersite variability of CSF Alzheimer's disease biomarkers in clinical setting. Alzheimers Dement (2012) 0.99
Alcohol consumption and carotid artery structure in older French adults: the Three-City Study. Stroke (2004) 0.99
KNG1 Ile581Thr and susceptibility to venous thrombosis. Blood (2011) 0.98
Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease. Curr Med Res Opin (2006) 0.97
Developing a global strategy to prevent Alzheimer's disease: Leon Thal Symposium 2010. Alzheimers Dement (2011) 0.97
Use of the PRIME-MD Patient Health Questionnaire for estimating the prevalence of psychiatric disorders in French primary care: comparison with family practitioner estimates and relationship to psychotropic medication use. Gen Hosp Psychiatry (2007) 0.97
Caffeine intake is associated with a lower risk of cognitive decline: a cohort study from Portugal. J Alzheimers Dis (2010) 0.96
Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dement Geriatr Cogn Disord (2007) 0.96
Enhanced detection of CNS cell secretome in plasma protein-depleted cerebrospinal fluid. J Proteome Res (2008) 0.95
Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling elderly (the ESPRIT study). Biol Psychiatry (2010) 0.95
Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol (2008) 0.95
Mild cognitive impairment: a nosological entity? Curr Opin Neurol (2003) 0.95
Lipid lowering agents, cognitive decline, and dementia: the three-city study. J Alzheimers Dis (2012) 0.95
Caffeine, cognitive functioning, and white matter lesions in the elderly: establishing causality from epidemiological evidence. J Alzheimers Dis (2010) 0.95
Determinants of excessive daytime sleepiness in a French community-dwelling elderly population. J Sleep Res (2007) 0.94
Long-term association of food and nutrient intakes with cognitive and functional decline: a 13-year follow-up study of elderly French women. Br J Nutr (2009) 0.94
Excessive daytime sleepiness and vascular events: the Three City Study. Ann Neurol (2012) 0.94
Proadrenomedullin, a useful tool for risk stratification in high Pneumonia Severity Index score community acquired pneumonia. Am J Emerg Med (2012) 0.94
The mental health of doctor-shoppers: experience from a patient-led fee-for-service primary care setting. J Affect Disord (2011) 0.93
Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study. J Am Geriatr Soc (2011) 0.93
Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents. J Alzheimers Dis (2010) 0.93
Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." The Multidomain Alzheimer Preventive Trial (MAPT): a new approach to the prevention of Alzheimer's disease. Alzheimers Dement (2009) 0.93